HbA1c as a predictor of diabetes after gestational diabetes mellitus

Primary Care Diabetes

Volumn 11, Issue 1, 2017, Pages 46-51

  Claesson, Rickard ^a,b   Ignell, Claes ^a,c   Shaat, Nael ^a,d   Berntorp, Kerstin ^a,d  

^a LUND UNIVERSITY   (Sweden)

^b Office for Healthcare Kryh   (Sweden)

^c Office for Healthcare Sund   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gestational diabetes; HbA1c; OGTT; Post partum diabetes; Prediction

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ARTICLE; BLOOD GLUCOSE METER; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; THIRD TRIMESTER PREGNANCY; AREA UNDER THE CURVE; BLOOD; GLUCOSE TOLERANCE TEST; METABOLISM; ODDS RATIO; PREGNANCY; REPRODUCIBILITY; RISK ASSESSMENT; STATISTICAL MODEL; TIME FACTOR;

AREA UNDER CURVE; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; GLYCATED HEMOGLOBIN A; HUMANS; LOGISTIC MODELS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS;

EID: 85007579601     PISSN: 17519918     EISSN: 18780210     Source Type: Journal    
DOI: 10.1016/j.pcd.2016.09.002     Document Type: Article

References (29)

1. [1] Bellamy, L., Casas, J.P., Hingorani, A.D., Williams, D., Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373 (2009), 1773–1779.
2. [2] Aroda, V.R., Christophi, C.A., Edelstein, S.L., et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J. Clin. Endocrinol. Metab. 100 (2015), 1646–1653.
3. [3] Tovar, A., Chasan-Taber, L., Eggleston, E., Oken, E., Postpartum screening for diabetes among women with a history of gestational diabetes mellitus. Prev. Chronic Dis., 8, 2011, A124.
4. [4] Shah, B.R., Lipscombe, L.L., Feig, D.S., Lowe, J.M., Missed opportunities for type 2 diabetes testing following gestational diabetes: a population-based cohort study. BJOG 118 (2011), 1484–1490.
5. [5] Picon, M.J., Murri, M., Munoz, A., et al. Hemoglobin A1c versus oral glucose tolerance test in postpartum diabetes screening. Diabetes Care 35 (2012), 1648–1653.
6. [6] Anderberg, E., Landin-Olsson, M., Kalen, J., et al. Prevalence of impaired glucose tolerance and diabetes after gestational diabetes mellitus comparing different cut-off criteria for abnormal glucose tolerance during pregnancy. Acta Obstet. Gynecol. Scand. 90 (2011), 1252–1258.
7. [7] Metzger, B.E., Gabbe, S.G., Persson, B., et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33 (2010), 676–682.
8. [8] World Health Organization, Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. 2013, World Health Organization, Geneva, Switzerland.
9. [9] American Diabetes Association, Classification and diagnosis of diabetes. Diabetes Care 38:Suppl (2015), S8–S16.
10. [10] Sacks, D.B., A1C versus glucose testing: a comparison. Diabetes Care 34 (2011), 518–523.
11. [11] Claesson, R., Ekelund, M., Ignell, C., Berntorp, K., Role of HbA1c in post-partum screening of women with gestational diabetes mellitus. J. Clin. Transl. Endocrinol. 2 (2015), 21–25.
12. [12] Megia, A., Näf, S., Herranz, L., et al. The usefulness of HbA1c in postpartum reclassification of gestational diabetes. BJOG 119 (2012), 891–894.
13. [13] Kim, C., Herman, W.H., Cheung, N.W., et al. Comparison of hemoglobin A1c with fasting plasma glucose and 2-h postchallenge glucose for risk stratification among women with recent gestational diabetes mellitus. Diabetes Care 34 (2011), 1949–1951.
14. [14] Noctor, E., Crowe, C., Carmody, L.A., et al. ATLANTIC DIP: simplifying the follow-up of women with previous gestational diabetes. Eur. J. Endocrinol. 169 (2013), 681–687.
15. [15] Gobl, C.S., Bozkurt, L., Yarragudi, R., et al. Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus?. Acta Diabetol. 51 (2014), 715–722.
16. [16] Su, X., Zhang, Z., Qu, X., et al. Hemoglobin A1c for diagnosis of postpartum abnormal glucose tolerance among women with gestational diabetes mellitus: diagnostic meta-analysis. PLoS One, 9, 2014, e102144.
17. [17] Ekelund, M., Shaat, N., Almgren, P., et al. Prediction of postpartum diabetes in women with gestational diabetes mellitus. Diabetologia 53 (2010), 452–457.
18. [18] Liu, H., Zhang, S., Wang, L., et al. Fasting and 2-hour plasma glucose, and HbA1c in pregnancy and the postpartum risk of diabetes among Chinese women with gestational diabetes. Diabetes Res. Clin. Pract. 112 (2016), 30–36.
19. [19] Kwon, S.S., Kwon, J.Y., Park, Y.W., et al. HbA1c for diagnosis and prognosis of gestational diabetes mellitus. Diabetes Res. Clin. Pract. 110 (2015), 38–43.
20. [20] Malinowska-Polubiec, A., Sienko, J., Lewandowski, Z., et al. Risk factors of abnormal carbohydrate metabolism after pregnancy complicated by gestational diabetes mellitus. Gynecol. Endocrinol. 28 (2012), 360–364.
21. [21] Bartakova, V., Maluskova, D., Muzik, J., et al. Possibility to predict early postpartum glucose abnormality following gestational diabetes mellitus based on the results of routine mid-gestational screening. Biochem. Med. 25 (2015), 460–468.
22. [22] Lind, T., Phillips, P.R., Influence of pregnancy on the 75-g OGTT. A prospective multicenter study. The Diabetic Pregnancy Study Group of the European Association for the Study of Diabetes. Diabetes 40:Suppl. 2 (1991), 8–13.
23. [23] Burnett, R.W., D'Orazio, P., Fogh-Andersen, N., et al. IFCC recommendation on reporting results for blood glucose. Clin. Chim. Acta 307 (2001), 205–209.
24. [24] World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. Part I: Diagnosis and Classification of Diabetes Mellitus., 1999, World Health Organization, Geneva, Switzerland.
25. [25] Hoelzel, W., Weykamp, C., Jeppsson, J.O., et al. Standardization, IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin. Chem. 50 (2004), 166–174.
26. [26] Hajian-Tilaki, K., Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J. Intern. Med. 4 (2013), 627–635.
27. [27] Dornhorst, A., Rossi, M., Risk and prevention of type 2 diabetes in women with gestational diabetes. Diabetes Care 21:Suppl. 2 (1998), B43–B49.
28. [28] Hsu, W.C., Boyko, E.J., Fujimoto, W.Y., et al. Pathophysiologic differences among Asians, native Hawaiians, and other Pacific Islanders and treatment implications. Diabetes Care 35 (2012), 1189–1198.
29. [29] Ignell, C., Ekelund, M., Anderberg, E., Berntorp, K., Model for individual prediction of diabetes up to 5 years after gestational diabetes mellitus. SpringerPlus, 5, 2016, 318.